Search Results

The Center for Fetal and Neonatal Care at Phoenix Children’s Hospital is partnering with providers who treat complex congenital diagnoses. Our goal is to provide a comprehensive overview of patient care for complex neonatal diagnosis.

At the end of this virtual presentation, participants should be able to: Discuss treatment options for extended-spectrum β-lactamase producing Enterobacterales infections Discuss the treatment options for Pseudomonas aeruginosa with difficult-to-treat resistance infections

Grand Rounds "N eurofibromatosis Type 1 in Children" At the end of this presentation, participants should be able to: Demonstrate proficiency in distinguishing between the various forms of neurofibromatosis syndromes in children Demonstrate proficiency in recognizing the early

The desired result is to facilitate the discussion of interesting, unique and difficult cases between the pediatric urology faculty to ensure that all patients are receiving consistent, high quality, evidence-based care. In addition, the conference will serve to educate the

This M&M conference reviews opportunities for care improvement based on real-life cases and areas where care was less than optimal and resulted in complications deaths that might have been prevented. Practice gap areas in trauma medicine that we have identified include

No recording is available for this session. Presenters: Juan Gurria, MD and Maisam Abu-El-Haija At the end of this presentation, participants should be able to: 1. Explain the diagnosis and work up updates of acute recurrent and chronic pancreatitis in children 2. Follow the

The Physicians and members of the healthcare team will appreciate new strategies in the management of critical illness. This will provide a comprehensive review of the clinical management, decision making, program and organizational processes related to the use of ECLS. This will

The recorded session is for internal use only. Please contact cme [at] phoenixchildrens.com for access.

Recorded session is for internal use only. Please email apeoples [at] phoenixchildrens.com to receive access information.

At the end of this presentation, participants should be able to: Explain Pediatric Dyslipidemia Subclinical State Apply Lipid Biomarkers for Pediatric Dyslipidemia Management Differentiate “Genetic Dyslipidemia” and “Atherogenic Dyslipidemia”